Bibw 2992, a Novel Irreversible Egfr/Her2 Tyrosine Kinase Inhibitor, in Chemonaive Patients with Adenocarcinoma of the Lung and Activating Egfr Mutations
Resource
JOURNAL OF THORACIC ONCOLOGY v.4 n.9 SUPPL. 1 pp.S294-S295
Journal
JOURNAL OF THORACIC ONCOLOGY
Journal Volume
v.4
Journal Issue
1
Pages
S294-S295
Date Issued
2009
Date
2009
Author(s)
YANG, CHIH-HSIN
SHIH, JIN-YUAN